Business & Finance
Teva CEO on Drug Pipeline, Direct Listing on NYSE
Key Points
Jul 29th, 2026 Teva CEO on Drug Pipeline, Direct Listing on NYSE Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.
Jul 29th, 2026
Teva CEO on Drug Pipeline, Direct Listing on NYSE
Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE.